742102-31-4Relevant articles and documents
COMPOUNDS FOR TREATMENT OF CYSTIC FIBROSIS
-
Paragraph 00225, (2015/01/16)
Described herein are compounds, compositions, and methods of their use for the treatment of cystic fibrosis.
COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
-
, (2012/04/23)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
ORGANIC COMPOUNDS
-
Page/Page column 39-40, (2009/01/20)
A compound of formula (I), or tautomers, or stereoisomers, or solvates, or pharmaceutically acceptable salts thereof, wherein M1, M2, L1, L2, W1, W2, X1, X2, Y1/